The normal ratio of th17 and th1 post-mesenchymal stem cells coculture with pbmcs of systemic lupus erythematosus patients

Ramasamy R., Nasihun T., Putra A., Kustiyah A.R.

Abstract

BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by altered T-cell population homeostasis, including Th1 and Th17 populations. Mesenchymal stem cell (MSC)-induced i-Treg in SLE milieu can suppress Th17 cell populations; however, Th1 cell population status as a response to the Th17 decrease remains unclear. Therefore, improving SLE flare by suppressing Th17 and constantly controlling Th1 under normal level through MSCs administration is crucial. AIM: This study aimed to investigate the role of MSCs in suppressing Th17 cell populations and controlling Th1 to a normal level by in vitro coculturing MSCs with PBMC from SLE patients.. METHODS: This study used a post-test control group design. MSCs were obtained from human umbilical cord blood and characterized according to their surface antigen expression and multilineage differentiation capacities. PBMCs isolated from SLE patients were divided into five groups: Sham, control, and three treatment groups. The treatment groups were treated by coculturing MSCs to PBMCs with a ratio of 1:10, 1:25, and 1:40 for 72 h incubation. Th1 and Th17 cells were analyzed by flow cytometry. RESULTS: This study showed that there was no significance difference of the percentages of Th1 cells on all treatment groups. On the other hand, the percentages of Th17 were significantly decreased on T1 group. Interestingly, there was also significant decrease of Th1-like Th17 cells population on T1 group. CONCLUSIONS: MSCs may suppress Th17 and control Th1 to a normal level by in vitro coculturing MSCs with PBMC from SLE.

Journal
Open Access Macedonian Journal of Medical Sciences
Page Range
169-176
Publication date
2021
Total citations
Cited by 5
Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineagespecific polarizing factors

Ayyoub M., Raffin C., Raimbaud I., Valmori D., Valmori D.

Interleukin-17 family members and inflammation

Kolls J.K., Linden A.

Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus

Feng X., Geng L., Geng L., Sun L., Sun Y., Tang X., Tsao B.P., Wang D., Wang S.

The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus

Feng X., Huang S., Liang J., Sun L., Wang D., Xu R., Yao G., Yuan X., Feng X., Huang S., Liang J., Sun L., Wang D., Xu R., Yao G., Yuan X.

Mesenchymal stem cells generate a CD4+CD25+Foxp3 + regulatory T cell population during the differentiation process of Th1 and Th17 cells

Bravo-Alegria J., Carrion F., Contreras R., Djouad F., Djouad F., Figueroa F., Jorgensen C., Jorgensen C., Jorgensen C., Kurte M., Luz-Crawford P., Luz-Crawford P., Luz-Crawford P., Noel D., Noel D., Nova-Lamperti E., Tejedor G., Tejedor G., Bravo-Alegria J., Carrion F., Contreras R., Djouad F., Djouad F., Figueroa F., Jorgensen C., Jorgensen C., Jorgensen C., Kurte M., Luz-Crawford P., Luz-Crawford P., Luz-Crawford P., Noel D., Noel D., Nova-Lamperti E., Tejedor G., Tejedor G., Bravo-Alegria J., Carrion F., Contreras R., Djouad F., Djouad F., Figueroa F., Jorgensen C., Jorgensen C., Jorgensen C., Kurte M., Luz-Crawford P., Luz-Crawford P., Luz-Crawford P., Noel D., Noel D., Nova-Lamperti E., Tejedor G., Tejedor G., Bravo-Alegria J., Carrion F., Contreras R., Djouad F., Djouad F., Figueroa F., Jorgensen C., Jorgensen C., Jorgensen C., Kurte M., Luz-Crawford P., Luz-Crawford P., Luz-Crawford P., Noel D., Noel D., Nova-Lamperti E., Tejedor G., Tejedor G.

The role of tnf-α induced mscs on suppressive inflammation by increasing tgf-β and il-10

Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K., Kustiyah A.R., Munir D., Putra A., Putra A., Putridewi A.I., Ridwan F.B., Rosdiana I., Sadyah N.A.C., Wirastuti K.

Mesenchymal stem cells induce regulatory t-cell population in human sle

Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B., Alif I., Darlan D.M., Ikhsan R., Kustiyah A.R., Munir D., Prasetio A., Putra A., Suntoko B.

MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC

Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A., Darlan D.M., Jusuf N.K., Munir D., Putra A.

The immunomodulatory capacity of mesenchymal stem cells

Gebler A., Seliger B., Zabel O., Gebler A., Seliger B., Zabel O.

Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow

Assadzadeh-Aghdaei H., Baghaei K., Hashemi S.M., Rad A.A., Sharifian A., Tokhanbigli S., Zali M.R., Assadzadeh-Aghdaei H., Baghaei K., Hashemi S.M., Rad A.A., Sharifian A., Tokhanbigli S., Zali M.R., Assadzadeh-Aghdaei H., Baghaei K., Hashemi S.M., Rad A.A., Sharifian A., Tokhanbigli S., Zali M.R.

The CD4+CD25+FoxP3+ Regulatory T Cells Regulated by MSCs Suppress Plasma Cells in a Mouse Model of Allergic Rhinitis

Ichwan M., Farhat F., Ilyas S., Sembiring R.J., Munir D., Madiadipoera T., Putra A., Restimulia L., Amalina N.D., Alif I.

Medical Archives

Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors’ Repertoire in the Recovery of Systemic Lupus Erythematosus

Mahmoudi M., Rezaieyazdi Z., Esmaeili S.-A., Hoseinzadeh A., Moradi R., Mahmoudi A., Heydari S., Afshari J.T.

Stem Cell Reviews and Reports

The role of mesenchymal stem cells in allergic rhinitis and its relationship with IL-10, plasma cells and regulatory T cells

Nasution I.P., Munir D., Putra A., Restimulia L., Amalina N.D.

Medicinski Glasnik

Therapeutic Potential of Secretome Hypoxia Mesenchymal Stem Cells: Downregulation of TNF-α and HIF-2α in Metabolic Syndrome-Induced Inflammation in Wistar Rats

Putra A., Sarosa H., Trisnadi S., Amalina N.D., Mulyani S.P., Ibrahim S., Dewi A.M., Chodijah C.

Biosaintifika

Peeling Back Immunity: Citrus Peel Extract as A Potential Natural Immunomodulator for Systemic Lupus Erythematosus

Alaydrus A.A., Alaydrus H.S.

Trends in Sciences

Access to Document

10.3889/oamjms.2021.5604